Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Illumina Inc ILMN

Illumina, Inc. is engaged in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. It is also a developer of an emerging and highly differentiated single-cell technology.


NDAQ:ILMN - Post by User

<< Previous
Bullboard Posts
Next >>
Post by R_J_on Dec 03, 2020 1:33am
292 Views
Post# 32024224

End of Month - November 2020

End of Month - November 2020End of the Month Report for November 2020 for Illumina Inc.
-
ILMN closed on 11/30/2020 at US$ 322.09
ILMN closed on 10/30/2020 at US$ 292.70
-
This is a   10.0% gain, a US$ 29.39 gain, for November
-
S&P 500 Index, @ 3621.63 gained 10.8% in November. [14.9% above its MA(200) @ 3152.9]
-
Two Hundred Day Moving Average [MA(200)] stuff.
ILMN's  MA(200) ended November at US$323.99
ILMN is now 0.6% below its MA(200).
-
News Release on the ILMN Website in November
-
Nov 18, 2020     
Illumina to Webcast Upcoming Investor Conference Presentation
-
Nov 12, 2020     
Realize the Full Potential of the NextSeq 2000 with the Power of the P3 Reagent Kit
-
Who is in charge?
Francis A. DeSouza, CEO
-
RJ


<< Previous
Bullboard Posts
Next >>